Overview
Diphtheria IgG refers to IgG-class antibodies directed against diphtheria toxin, as described in the document. These antibodies primarily target the A and B subunits of the diphtheria toxin and play a critical role in neutralizing the toxin before it binds to host cells. Diphtheria is caused by the bacterium Corynebacterium diphtheriae, and disease severity is largely determined by toxin production rather than bacterial invasion alone.
The document explains that Diphtheria IgG antibodies are produced after natural infection or following vaccination with diphtheria toxoid. Measurement of Diphtheria IgG is used to assess immunity status, evaluate the immune response after vaccination, determine the need for booster doses, and support epidemiological surveillance. Unlike tests used for direct diagnosis of active infection, Diphtheria IgG testing focuses on protective immunity against the toxin.
Symptoms
Diphtheria IgG antibodies themselves do not cause symptoms. Clinical symptoms arise from diphtheria infection in individuals who lack sufficient protective antibodies, as outlined in the document.
When immunity is inadequate, diphtheria infection may present with:
- Sore throat
- Fever
- Formation of a thick pseudomembrane over the throat or tonsils
- Difficulty swallowing or breathing
- Swollen cervical lymph nodes
In severe cases, diphtheria toxin can cause systemic complications, including cardiac and neurological involvement. The document highlights that individuals with adequate IgG antibody levels are typically protected from toxin-mediated disease, even if exposed to the bacterium.
Diphtheria IgG testing is therefore particularly useful in individuals without clear vaccination records, those at risk of waning immunity, or during outbreak investigations.
Causes
Diphtheria IgG positivity is caused by prior exposure to diphtheria toxoid through vaccination or natural infection, as stated in the document. Vaccination stimulates the immune system to produce neutralizing antibodies against the diphtheria toxin.
Causes of low or absent Diphtheria IgG levels include:
- Lack of prior vaccination
- Incomplete vaccination schedules
- Waning immunity over time
- Immunodeficiency conditions
- Poor immune response after vaccination
The document explains that antibody levels may decline gradually with age, even in previously vaccinated individuals. This decline can result in reduced protection, highlighting the importance of periodic assessment and booster vaccination.
Risk Factors
Risk factors for inadequate Diphtheria IgG levels are primarily related to vaccination status, immune competence, and time since last immunization, as outlined in the document.
Key risk factors include:
- Individuals who have never been vaccinated against diphtheria
- Delayed or incomplete childhood immunization
- Long intervals since last booster dose
- Advanced age, due to declining antibody levels
- Immunocompromised states affecting antibody production
The document notes that antibody levels below protective thresholds indicate susceptibility to diphtheria, while intermediate levels may provide only short-term or partial protection. Risk assessment using Diphtheria IgG testing helps identify individuals who require booster vaccination, especially in high-risk populations or outbreak settings.
Prevention
Diphtheria IgG antibody formation cannot be forced once immunity has waned, but diphtheria infection is preventable through appropriate vaccination, as emphasized in the document.
Preventive strategies include:
- Primary immunization with diphtheria toxoid–containing vaccines
- Timely administration of booster doses
- Monitoring antibody levels in individuals with uncertain vaccination history
- Identifying waning immunity before exposure occurs
From a clinical and public health perspective, prevention also involves:
- Using Diphtheria IgG testing to assess protection levels
- Administering booster doses when antibody levels fall below protective thresholds
- Supporting outbreak investigations and population-level immunity monitoring
